1. Home
  2. LUNG vs CMTL Comparison

LUNG vs CMTL Comparison

Compare LUNG & CMTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • CMTL
  • Stock Information
  • Founded
  • LUNG 1995
  • CMTL 1967
  • Country
  • LUNG United States
  • CMTL United States
  • Employees
  • LUNG N/A
  • CMTL N/A
  • Industry
  • LUNG Industrial Specialties
  • CMTL Radio And Television Broadcasting And Communications Equipment
  • Sector
  • LUNG Health Care
  • CMTL Technology
  • Exchange
  • LUNG Nasdaq
  • CMTL Nasdaq
  • Market Cap
  • LUNG 65.6M
  • CMTL 64.4M
  • IPO Year
  • LUNG 2020
  • CMTL N/A
  • Fundamental
  • Price
  • LUNG $1.55
  • CMTL $2.43
  • Analyst Decision
  • LUNG Buy
  • CMTL Strong Buy
  • Analyst Count
  • LUNG 7
  • CMTL 1
  • Target Price
  • LUNG $7.66
  • CMTL $6.00
  • AVG Volume (30 Days)
  • LUNG 480.4K
  • CMTL 152.3K
  • Earning Date
  • LUNG 10-29-2025
  • CMTL 10-30-2025
  • Dividend Yield
  • LUNG N/A
  • CMTL N/A
  • EPS Growth
  • LUNG N/A
  • CMTL N/A
  • EPS
  • LUNG N/A
  • CMTL N/A
  • Revenue
  • LUNG $90,549,000.00
  • CMTL $495,352,000.00
  • Revenue This Year
  • LUNG $10.30
  • CMTL N/A
  • Revenue Next Year
  • LUNG $14.72
  • CMTL N/A
  • P/E Ratio
  • LUNG N/A
  • CMTL N/A
  • Revenue Growth
  • LUNG 18.24
  • CMTL N/A
  • 52 Week Low
  • LUNG $1.47
  • CMTL $1.19
  • 52 Week High
  • LUNG $9.37
  • CMTL $5.16
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 37.40
  • CMTL 63.48
  • Support Level
  • LUNG $1.60
  • CMTL $2.19
  • Resistance Level
  • LUNG $1.76
  • CMTL $2.37
  • Average True Range (ATR)
  • LUNG 0.13
  • CMTL 0.16
  • MACD
  • LUNG 0.02
  • CMTL 0.04
  • Stochastic Oscillator
  • LUNG 2.86
  • CMTL 81.84

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About CMTL Comtech Telecommunications Corp.

Comtech Telecommunications Corp is a provider of modern communications solution incorporated in USA. The company is engaged in designing, developing, producing and marketing products, systems, and services for communications solutions. It is engaged in two business segments, Satellite and Space Communications and Terrestrial and Wireless Networks. It's Space and satellite is USA based providers of modems and high-power amplifiers, a market leader in troposcatter technologies, and serves some of the world's defense contractors and allied foreign governments. Terrestrial and Wireless Networks segment is a provider of next generation 911 infrastructure and solutions for state and local governments and carriers. Majority of sales are generated from Satellite and Space Communications segment.

Share on Social Networks: